IOBT
IO Biotech, Inc.$0.01+0.01 (+30.65%)Prev Close$0.03·MCap$885,690·P/E—·Vol175.50M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
IOBT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | Hunter Heidi | Director | Buy | 15,000 | $1.39 | $20.9K | 0 |
| Dec 26, 2024 | Ahmad Qasim Iftikhar | Chief Medical Officer | Buy | 31,350 | $0.85 | $26.6K | 31,350 |
| Dec 23, 2024 | Smith Devin Whittemore | General Counsel | Buy | 12,000 | $0.81 | $9.7K | 16,938+243% |
| Dec 23, 2024 | Sullivan Amy | Chief Financial Officer | Buy | 10,250 | $0.83 | $8.5K | 84,632 |
| Dec 23, 2024 | Zocca Mai-Britt | Chief Executive Officer | Buy | 12,500 | $0.81 | $10.1K | 49,891+33% |
| Jul 26, 2024 | Novo Holdings A/S | Sell | 75,000 | $1.32 | $99.1K | 4,377,927 | |
| May 14, 2024 | Novo Holdings A/S | Sell | 658,809 | $1.22 | $802.5K0.9% OS | 4,429,449 | |
| Feb 13, 2024 | Novo Holdings A/S | 10% Owner | Sell | 658,809 | $1.50 | $988.4K0.9% OS | 5,088,258 |
| Nov 24, 2023 | Burkavage Brian | Chief Accounting Officer | Buy | 10,000 | $1.01 | $10.1K | 11,500+667% |
| Aug 11, 2023 | Novo Holdings A/S | 10% Owner | Buy | 2,469,135 | $2.03 | $5.00M3.4% OS | 5,707,467+76% |
| Aug 10, 2023 | Vivo Capital IX, LLC | 10% Owner | Buy | 3,157,894 | $1.90 | $6.00M4.4% OS | 3,157,894 |
| Mar 20, 2023 | Sullivan Amy | Chief Financial Officer | Buy | 25,000 | $2.32 | $58.0K | 25,000 |
| Nov 12, 2021 | Andersson Claus A. | Buy | 75,000 | $14.00 | $1.05M | 1,791,490 | |
| Nov 12, 2021 | HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Buy | 325,000 | $14.00 | $4.55M | 2,690,545 |
| Nov 12, 2021 | Lundbeckfond Invest A/S | Buy | 2,142,857 | $14.00 | $30.00M3.0% OS | 6,049,452+55% | |
| Nov 12, 2021 | Malier Vanessa | Buy | 162,500 | $14.00 | $2.27M | 958,559 | |
| Nov 12, 2021 | Vivo Capital IX, LLC | Buy | 650,000 | $14.00 | $9.10M0.9% OS | 3,015,545+27% | |
| Nov 10, 2021 | Novo Holdings A/S | 10% Owner | Buy | 325,000 | $14.00 | $4.55M | 3,277,932 |
IOBT Insider Buying Activity
The following table shows recent insider purchases of IO Biotech, Inc. (IOBT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | Hunter Heidi | Director | Buy | 15,000 | $1.39 | $20.9K | 0 |
| Dec 26, 2024 | Ahmad Qasim Iftikhar | Chief Medical Officer | Buy | 31,350 | $0.85 | $26.6K | 31,350 |
| Dec 23, 2024 | Smith Devin Whittemore | General Counsel | Buy | 12,000 | $0.81 | $9.7K | 16,938+243% |
| Dec 23, 2024 | Sullivan Amy | Chief Financial Officer | Buy | 10,250 | $0.83 | $8.5K | 84,632 |
| Dec 23, 2024 | Zocca Mai-Britt | Chief Executive Officer | Buy | 12,500 | $0.81 | $10.1K | 49,891+33% |
| Nov 24, 2023 | Burkavage Brian | Chief Accounting Officer | Buy | 10,000 | $1.01 | $10.1K | 11,500+667% |
| Aug 11, 2023 | Novo Holdings A/S | 10% Owner | Buy | 2,469,135 | $2.03 | $5.00M3.4% OS | 5,707,467+76% |
| Aug 10, 2023 | Vivo Capital IX, LLC | 10% Owner | Buy | 3,157,894 | $1.90 | $6.00M4.4% OS | 3,157,894 |
| Mar 20, 2023 | Sullivan Amy | Chief Financial Officer | Buy | 25,000 | $2.32 | $58.0K | 25,000 |
| Nov 12, 2021 | Andersson Claus A. | Buy | 75,000 | $14.00 | $1.05M | 1,791,490 | |
| Nov 12, 2021 | HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Buy | 325,000 | $14.00 | $4.55M | 2,690,545 |
| Nov 12, 2021 | Lundbeckfond Invest A/S | Buy | 2,142,857 | $14.00 | $30.00M3.0% OS | 6,049,452+55% | |
| Nov 12, 2021 | Malier Vanessa | Buy | 162,500 | $14.00 | $2.27M | 958,559 | |
| Nov 12, 2021 | Vivo Capital IX, LLC | Buy | 650,000 | $14.00 | $9.10M0.9% OS | 3,015,545+27% | |
| Nov 10, 2021 | Novo Holdings A/S | 10% Owner | Buy | 325,000 | $14.00 | $4.55M | 3,277,932 |
IOBT Insider Selling Activity
The following table shows recent insider sales of IO Biotech, Inc. (IOBT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 26, 2024 | Novo Holdings A/S | Sell | 75,000 | $1.32 | $99.1K | 4,377,927 | |
| May 14, 2024 | Novo Holdings A/S | Sell | 658,809 | $1.22 | $802.5K0.9% OS | 4,429,449 | |
| Feb 13, 2024 | Novo Holdings A/S | 10% Owner | Sell | 658,809 | $1.50 | $988.4K0.9% OS | 5,088,258 |
IOBT Insiders
Similar Stocks to IOBT
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B